Gene · 3713
Papers3,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,341 to 1,360 of 3,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unravelling effects of relative humidity on lipid barrier formation in human skin equivalents. | Arch Dermatol Res | 2019 | 31321505 | PubTator, text mining | PubMed |
| Stem cells in tissues, organoids, and cancers. | Cell Mol Life Sci | 2019 | 31317205 | PubTator, text mining | PubMed |
| Clinical and in vitro evaluation of new anti-redness cosmetic products in subjects with winter xerosis and sensitive skin. | Int J Cosmet Sci | 2019 | 31309600 | PubTator, text mining | PubMed |
| Hydrogel scaffold with substrate elasticity mimicking physiological-niche promotes proliferation of functional keratinocytes. | RSC Adv | 2019 | 31304009 | PubTator, text mining | PubMed |
| Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer. | Cancer Cell Int | 2019 | 31297036 | PubTator, text mining | PubMed |
| Generation and Clinical Application of Gene-Modified Autologous Epidermal Sheets in Netherton Syndrome: Lessons Learned from a Phase 1 Trial. | Hum Gene Ther | 2019 | 31288584 | PubTator, text mining | PubMed |
| On the relationship between VDR, RORα and RORγ receptors expression and HIF1-α levels in human melanomas. | Exp Dermatol | 2019 | 31287590 | PubTator, text mining | PubMed |
| Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13Rα2 in Keratinocytes. | Int J Mol Sci | 2019 | 31284553 | PubTator, text mining | PubMed |
| The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis. | Int J Mol Sci | 2019 | 31284527 | PubTator, text mining | PubMed |
| Identification of crucial miRNAs and genes in esophageal squamous cell carcinoma by miRNA-mRNA integrated analysis. | Medicine (Baltimore) | 2019 | 31277149 | PubTator, text mining | PubMed |
| Keratinocyte-derived IL-36γ plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes. | Arch Toxicol | 2019 | 31256213 | PubTator, text mining | PubMed |
| Interplay of MicroRNA-21 and SATB1 in Epidermal Keratinocytes during Skin Aging. | J Invest Dermatol | 2019 | 31255698 | PubTator, text mining | PubMed |
| Immortalized Human hTert/KER-CT Keratinocytes a Model System for Research on Desmosomal Adhesion and Pathogenesis of Pemphigus Vulgaris. | Int J Mol Sci | 2019 | 31247885 | PubTator, text mining | PubMed |
| Use of formulations for sensitive skin improves the visible signs of aging, including wrinkle size and elasticity. | Clin Cosmet Investig Dermatol | 2019 | 31239745 | PubTator, text mining | PubMed |
| A Proteomic View of Cellular Responses to Anticancer Quinoline-Copper Complexes. | Proteomes | 2019 | 31238524 | PubTator, text mining | PubMed |
| Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque Psoriasis. | Sci Rep | 2019 | 31235749 | PubTator, text mining | PubMed |
| Filaggrin and atopic march. | Biochem Med (Zagreb) | 2019 | 31223255 | PubTator, text mining | PubMed |
Water-Soluble Extract from Actinidia arguta (Siebold & Zucc.) Planch. ex Miq. and Perilla frutescens (L.) Britton, ACTPER, Ameliorates a Dry Skin-Induced Itch in a Mice Model and Promotes Filaggrin Expression by Activating the AhR Signaling in HaCaT Cells. | Nutrients | 2019 | 31216667 | PubTator, text mining | PubMed |
| Induction of hair follicle neogenesis with cultured mouse dermal papilla cells in de novo regenerated skin tissues. | J Tissue Eng Regen Med | 2019 | 31216101 | PubTator, text mining | PubMed |
| The expression of S100A8/S100A9 is inducible and regulated by the Hippo/YAP pathway in squamous cell carcinomas. | BMC Cancer | 2019 | 31208368 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3713/papers?page=68